The grants will support more than 50 research and clinical projects, purchase scientific equipment and fund recruitment.
New findings could help scientists develop treatments for the condition known as ITP.
This collaboration is part of GSK’s “Discovery Partnerships with Academia” (DPAc) efforts.
Visiting attendees represented some of the top names in in the industry.
OMRF and three other institutions are jointly studying age-related muscle loss.
The project is focused on lupus, which affects up to 1.5 million Americans.